Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Helle Charlotte Knudsen"'
Autor:
Mette Ølgod Pedersen, Marie Fredslund Breinholt, Tim Svenstrup Poulsen, Signe Ledou Nielsen, Peter Nørgaard, Anne Ortved Gang, Tobias Wirenfeldt Klausen, Helle Charlotte Knudsen, Erik Clasen-Linde, Estrid Høgdall
Publikováno v:
European Journal of Haematology. 102:395-406
Objective In patients with large B-cell lymphoma (LBCL) according to WHO, the prognostic significance of MYC translocation is still not sufficiently clarified. We therefore aimed to investigate whether prognostication could be improved in patients wi
Autor:
Marie Fredslund Breinholt, Erik Clasen-Linde, Estrid Høgdall, Lone Schejbel, Peter Nørgaard, Mette Ølgod Pedersen, Tobias Wirenfeldt Klausen, Anne Ortved Gang, Mette Vestergaard Elbæk, Douglas Vnp Oliveira, Signe Ledou Nielsen, Helle Charlotte Knudsen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf64bda85bf004c4d614f63e5ae74d26
https://doi.org/10.1002/hon.2839/v2/response1
https://doi.org/10.1002/hon.2839/v2/response1
Autor:
Peter Nørgaard, Douglas Vnp Oliveira, Lone Schejbel, Signe Ledou Nielsen, Helle Charlotte Knudsen, Erik Clasen-Linde, Estrid Høgdall, Mette Vestergaard Elbæk, Tobias Wirenfeldt Klausen, Mette Ølgod Pedersen, Anne Ortved Gang, Marie Fredslund Breinholt
Publikováno v:
Hematological oncologyREFERENCES. 39(3)
Extensive molecular analysis of large B-cell lymphomas (LBCL) have provided basis for new concepts of lymphoma taxonomy. These include stages of differentiation, phenotype (cell of origin) as well as genotype (including, but not confined to gene rear
Autor:
Anupama Reddy, Sandeep S. Dave, Erik Clasen-Linde, Estrid Høgdall, Peter Nørgaard, Signe Ledou Nielsen, Marie Fredslund Breinholt, Mette Vestergaard Elbæk, Cassandra Love, Mette Ølgod Pedersen, Helle Charlotte Knudsen, Anne Ortved Gang
Publikováno v:
Hematological oncologyREFERENCES. 37(4)
Introduction: In large B-cell lymphoma (LBCL) MYC translocation and MYC/BCL2 or BCL6 double hit (DH) is associated with poor prognosis and there is an unmet need for novel treatment targets in this patient group. Treatment targeting the PD-L1/PD-1 pa
Autor:
Hans Carl Hasselbalch, Karsten Nielsen, Helle Charlotte Knudsen, Ann Brinch Madelung, Preben Løvgreen, Jürgen Thiele, Anne Falensteen, Henrik Bondo, Kira Dynnes Svendsen, Elisabeth Ralfkiaer, Signe Ledou Nielsen, Theis Lange, Inger Stamp
Publikováno v:
APMIS. 123:787-792
We examined the learning effect of a workshop for Danish hematopathologists led by an international expert regarding histological subtyping of myeloproliferative neoplasms (MPN). Six hematopathologists evaluated 43 bone marrow (BM) biopsies according
Autor:
Peter Nørgaard, Michael Pedersen, Anne F. Lauritzen, Estrid Høgdall, Anne O. Gang, Peter de Nully Brown, Helle Charlotte Knudsen, Mette Ø. Pedersen, Signe Ledou Nielsen, Tim Svenstrup Poulsen
Publikováno v:
Experimental Hematology. 43:534-536
Topoisomerase (TOP) gene copy number changes may predict response to treatment with TOP-targeting drugs in cancer treatment. This was first described in patients with breast cancer and is currently being investigated in other malignant diseases. TOP-
Autor:
Helle Charlotte Knudsen, M.L. Espersen, Estrid Høgdall, Marie Fredslund Breinholt, Peter Nørgaard, Mette Ølgod Pedersen, Signe Ledou Nielsen, Anne Ortved Gang
Publikováno v:
Hematological Oncology. 35:293-294
Autor:
Tim Svenstrup Poulsen, Helle Charlotte Knudsen, Anne Ortved Gang, Tobias Wirenfeldt Klausen, Estrid Høgdall, Peter Brown, Peter Nørgaard, Michael Pedersen, Mette Ølgod Pedersen, Signe Ledou Nielsen
Publikováno v:
Pedersen, M Ø, Gang, A O, Brown, P, Pedersen, M, Knudsen, H, Nielsen, S L, Poulsen, T, Wirenfeldt Klausen, T, Høgdall, E & Nørgaard, P 2017, ' Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP-MYC, BCL2 and BCL6 as prognostic biomarkers ', PloS one, vol. 12, no. 10, e0186983 . https://doi.org/10.1371/journal.pone.0186983
PLoS ONE, Vol 12, Iss 10, p e0186983 (2017)
PLoS ONE
PLoS ONE, Vol 12, Iss 10, p e0186983 (2017)
PLoS ONE
BACKGROUND: Double expression of MYC and BCL2 proteins (DE) and double-hit MYC+BCL2/BCL6 translocations (DH) were established as important biomarkers in patients with diffuse large B-cell lymphoma (DLBCL) by the 2016 revision of the World Health Orga
Autor:
Helle Charlotte Knudsen, Bent Ejlertsen, Henning T. Mouridsen, Susanne Møller, Jan Trøst Jørgensen, Ann Knoop, Kirsten Vang Nielsen
Publikováno v:
Nielsen, K V, Ejlertsen, B, Møller, S, Jørgensen, J T, Knoop, A, Knudsen, H & Mouridsen, H T 2008, ' The value of TOP2A gene copy number variation as a biomarker in breast cancer : Update of DBCG trial 89D ', Acta Oncologica, vol. 47, no. 4, pp. 725-734 . https://doi.org/10.1080/02841860801995396
Udgivelsesdato: 2008 BACKGROUND: Previous analyses of TOP2A and HER2 in the Danish Breast Cancer Coopererative Group (DBCG) trial 89D suggested that TOP2A amplifications and possible also deletions are predictive markers for the effect of adjuvant ep
Autor:
Michael Pedersen, Peter Nørgaard, Anne O. Gang, Tobias Wirenfeldt Klausen, Peter de Nully Brown, Mette Ø. Pedersen, Helle Charlotte Knudsen, Anne F. Lauritzen, Estrid Høgdall, Signe Ledou Nielsen
Publikováno v:
Leukemialymphoma. 56(7)
Addition of etoposide to the R-CHOP chemotherapy regimen with cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab (R-CHOEP) has resulted in improved survival in young patients with high-risk diffuse large B-cell lymphoma (DLBCL). It